Enjoying ad-free content?
Since July 1, 2024, we have disabled all ads to improve your reading experience.
This commitment costs us $10,000 a month. Your support can help us fill the gap.
Support us
Our journalism is banned in Russia. We need your help to keep providing you with the truth.

Takeda Gets License

Japanese pharmaceuticals company Takeda secured a production license for its factory in Yaroslavl, the company announced last week, Interfax reported. Construction was completed in September 2012.

The factory can produce drugs in solid and liquid form, including sterile solutions for injection, pills with various coatings and uncoated pills.

Under the license, the factory can manufacture both Takeda's own drugs and those of other companies with which it has contracts. The factory is expected to initially produce 90 million sterile ampoules and vials and more than 2 billion pills per year.

Takeda plans to begin packaging injection drugs this summer and begin full production at the start of 2014. The company invested 75 million euros ($98 million) in the facility, which is in the Yaroslavl pharmaceuticals cluster.


… we have a small favor to ask. As you may have heard, The Moscow Times, an independent news source for over 30 years, has been unjustly branded as a "foreign agent" by the Russian government. This blatant attempt to silence our voice is a direct assault on the integrity of journalism and the values we hold dear.

We, the journalists of The Moscow Times, refuse to be silenced. Our commitment to providing accurate and unbiased reporting on Russia remains unshaken. But we need your help to continue our critical mission.

Your support, no matter how small, makes a world of difference. If you can, please support us monthly starting from just $2. It's quick to set up, and you can be confident that you're making a significant impact every month by supporting open, independent journalism. Thank you.

paiment methods
Not ready to support today?
Remind me later.

Read more